Sernova (TSE:SVA) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Sernova Corp., a clinical-stage biotech company, has announced the appointment of Jonathan Rigby to its Board of Directors. Rigby, with over three decades of biopharmaceutical experience and a personal connection to Type 1 diabetes, brings a wealth of industry knowledge from his previous leadership roles and board positions. His addition is expected to significantly contribute to Sernova’s mission to develop cell therapy treatments for chronic diseases, including a ‘functional cure’ for Type 1 diabetes.
For further insights into TSE:SVA stock, check out TipRanks’ Stock Analysis page.
